Advances in Hidradenitis Suppurativa

Multimedia Medical Education

Supported by an educational grant from AbbVie.*
Medical accuracy confirmed at release date.

Recent Advances in Our Understanding and Management of HS: From Mild to Worsening HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Combined Medical and Surgical Approaches in Moderate-to-Severe HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Troubling Cases of HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Ask the Faculty
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Modifying the Impact of HS: Lifestyle Considerations
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Thrasyvoulos Tzellos, MD, MSc, PhD
Release Date: 15 October 2018
Addressing the Psychosocial Symptoms of HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018
Easing the Pain: Approaches for Clinicians Managing HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Falk G. Bechara, MD
Release Date: 15 October 2018
What’s the Goal? Perspectives on What We Want to Achieve for Patients With HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018

Faculty Communications

Case Studies, Literature Reviews, and Survey Results

Highlights from the 6th EHSF Conference in 2017
Kelsey R. van Straalen, MD
Hessel H van der Zee, MD

Join the Discussion
Survey Report: How Do Clinicians Approach the Management of Hidradenitis Suppurativa?
Caitriona Ryan, MD

Join the Discussion
Literature Review: Evaluating the Psychological Burden of HS and Its Impact on Relationships and Sexual Function
Hessel H van der Zee, MD, PhD

Join the Discussion

Patient Case Studies

56-year-old woman, with history of psoriasis well controlled on ustekinumab, underwent 18F-FDG PET/CT to explore first onset...

69-year-old man with a long history of psoriasis who developed acute respiratory distress during a disease flare-up. There...

53-year-old woman. In our patient, the source of infection was probably the sand and soil at a Swiss lake. This case report...

See more >>

In the News

Increased Mortality After MI in Young Adults With Systemic Inflammatory Disease
Myocardial infarctions (MI) in young adults are twice as likely to be fatal in those with inflammatory conditions like psoriasis, lupus, or rheumatoid arthritis, according to results from a study published in the European Journal of Preventive Cardiology. “This suggests that the worse long-term...
AAD Releases First-Ever Guidelines for Treating Paediatric Patients With Psoriasis
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released guidelines to help ensure that paediatric psoriasis patients receive the best possible treatment and care. The joint AAD/NPF guidelines, published in the Journal of the American Academy of...
Psoriasis Appears Associated With Increased Risk of Developing, Dying of Cancer
Patients with psoriasis appear to have an increased risk of cancer incidence and cancer-related mortality, according to a study published in JAMA Dermatology. For the study, Alex Trafford, University of Manchester, Manchester, United Kingdom, and colleagues searched through 6 electronic databases...
See more >>

Conference Reports

Deucravacitinib Effective for Patients With Active Psoriatic Arthritis

By Louise Gagnon

OTTAWA, Ontario -- November 12, 2020 -- Deucravacitinib was effective, compared with placebo, over 16 weeks of treatment in patients with active psoriatic arthritis (PsA), according to a study presented at the 2020 Virtual Meeting of the American College of Rheumatology (...

Tildrakizumab Improves Joint, Skin Manifestations of Psoriatic Arthritis

By Denise Baez

NEW YORK -- November 5, 2020 -- Tildrakizumab improved joint and skin manifestations of psoriatic arthritis better than placebo through 52 weeks, and was well tolerated among patients, according to a study presented at the Virtual 29th Congress of the European Academy of...

Therapeutic Drug Monitoring Does Not Improve Remission Rates in Patients Starting Infliximab Therapy

By Eric Ramos

CHICAGO -- June 9, 2020 -- Therapeutic drug monitoring in patients with rheumatic diseases who are starting treatment with infliximab does not appear to be superior to standard treatment in order to achieve remission, according to a study presented at the 2020 Virtual...

see more >>

Recently Published

The study of dry eye and meibomian glands in psoriasis
Ahmad Reza Taheri, Elahe Allahyari, Mostafa Zeinaly, Malihe Nikandish
Being overweight is associated with not reaching low disease activity in women but not men with Psoriatic Arthritis
Michelle L M Mulder, Mark H Wenink, Johanna E Vriezekolk
Long-term Outcomes and Prognosis in New-Onset Psoriasis
Axel Svedbom, Lotus Mallbris, Per Larsson, Pernilla Nikamo, Katarina Wolk, Petra Kjellman, Enikö Sonkoly, Liv Eidsmo, Ulla Lindqvist, Mona Ståhle
See more >>

Full-Text Articles

BMC Musculoskeletal Disorders
Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab
Andrew Chandler, Meredith K Bartelstein, Tomohiro Fujiwara, Cristina R Antonescu, John H Healey, Max Vaynrub
Medicine (Baltimore)
Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors
Marco Di Carlo, Andrea Becciolini, Antonella Incorvaia, Giacomo Beci, Gianluca Smerilli, Martina Biggioggero, Marika Tardella, Rossella De Angelis, Fausto Salaffi
Journal of Rheumatology
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
Gurjit S Kaeley, Lihi Eder, Sibel Zehra Aydin, Phoebe Rich, Catherine J Bakewell
See more >>

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.